RESEARCH TEAMS PURSUING BEST ONCOLOGY CARE IN EARLY PHASE CLINICAL TRIALS

被引：0
作者：
Brown, Sarah [1 ]
Mencias, Candace [1 ]
Seehausen, Paige [1 ]
Mullenbach, Alli [1 ]
Marsolini, Trisha [1 ]
机构：
[1] Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
ONCOLOGY NURSING FORUM | 2024年 / 51卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P44
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Institutional review of pediatric oncology patients participating in early phase clinical trials.
    Rami, Avina
    Bona, Kira
    Shusterman, Suzanne
    Wright, Karen D.
    Place, Andrew E.
    Umaretiya, Puja J.
    Bhushan, Ketki
    DuBois, Steven G.
    Campbell, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Assessing Compliance and Diversity in Early Phase Radiation Oncology Clinical Trials in the United States
    Rezaei, S. A.
    Price, A. T.
    McClelland, S., III
    Henke, L. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E59 - E59
  • [43] Phase II Trials in Journal of Clinical Oncology
    Cannistra, Stephen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3073 - 3076
  • [44] Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs
    Takashi Ogura
    Satoshi Morita
    Kan Yonemori
    Takahiro Nonaka
    Tsutomu Urano
    Therapeutic Innovation & Regulatory Science, 2014, 48 : 644 - 650
  • [45] Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie
    Surun, Aurore
    Dujaric, Marie-Eglantine
    Aerts, Isabelle
    Orbach, Daniel
    Jimenez, Irene
    Pacquement, Helene
    Schleiermacher, Gudrun
    Bourdeaut, Franck
    Michon, Jean
    Dupont, Jean-Claude K.
    Doz, Francois
    PEDIATRIC BLOOD & CANCER, 2018, 65 (05)
  • [46] Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs
    Ogura, Takashi
    Morita, Satoshi
    Yonemori, Kan
    Nonaka, Takahiro
    Urano, Tsutomu
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (05) : 644 - 650
  • [47] Design considerations for early-phase clinical trials of immune-oncology agents
    Wages, Nolan A.
    Chiuzan, Cody
    Panageas, Katherine S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [48] Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
    Liu, Jia
    Farrow, Max
    Seymour, Lesley
    Desai, Jayesh
    Loong, Herbert H.
    Ivy, Percy
    Koyoma, Takafumi
    Cook, Natalie
    Blagden, Sarah
    Garralda, Elena
    Massard, Christophe
    Tolcher, Anthony W.
    Adashek, Jacob J.
    Zhang, Li
    Zhao, Shen
    Shen, Lin
    Kurzrock, Razelle
    El-Deiry, Wafik S.
    Subbiah, Vivek
    Joshua, Anthony M.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (06)
  • [49] Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?
    Suji Udayakumar
    Sasha Thomson
    Albiruni R. Abdul Razak
    Kelvin K. W. Chan
    Targeted Oncology, 2022, 17 : 665 - 674
  • [50] Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials
    Faruqi, Aiman J.
    Ligon, John A.
    Cohen, Julia W.
    Akshintala, Srivandana
    Widemann, Brigitte C.
    Shah, Nirali N.
    ONCOLOGIST, 2022, 27 (08) : E681 - E682
12345